Skip to main navigation Skip to search Skip to main content

Large-cohort screening projects in seven regions of China demonstrate the efficacy of extended HPV genotyping in triaging HPV-positive women

  • Wenkui Dai (Co-first Author)
  • , Yu Liu (Co-first Author)
  • , Hui Du (Co-first Author)
  • , Chunlei Guo
  • , Di Wu
  • , Xin Jiang
  • , Shuai Cheng Li
  • , Changzhong Li (Co-last Author)
  • , Xinfeng Qu (Co-last Author)
  • , Ruifang Wu* (Co-last Author)
  • *Corresponding author for this work

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

2 Downloads (CityUHK Scholars)

Abstract

Objective: To assess the triage efficacy of extended HPV genotyping for human papillomavirus (HPV)-positive women, using data from five large population-based cohort screening studies across seven regions in China.
Methods: We analyzed 7821 HPV-positive cases among 116,042 screening attendees. The incidence of cervical intraepithelial neoplasia (CIN) grades 3+ was evaluated for single HPV infections. HPV genotypes conferring high CIN3+ risks as single infections were selected for triaging HPV-positive cases and compared with strategy recommended in current screening guidelines.
Results: The top five HPV subtypes were HPV-16, 52, 58, 51, and 18. Single HPV16 infection carried the highest risk of CIN3+ incidence. Single infections with HPV31, 33, 52, and 58 also exhibited elevated CIN3+ rates. Using CIN3+ as the primary endpoint, we evaluated extended genotyping-based triage strategies without relying on cytology. The results showed that the extended genotyping strategies (HPV-16/18/31/33/35/45/52/58 and HPV-16/18/31/33/52/58) were non-inferior to the standard strategy (HPV-16/18 combined with cytology) in CIN3+ detection (97.7% vs 97.1%, P = 0.1540; 97.3% vs 97.1%, P = 0.1485, respectively).
Conclusion: Extended HPV genotyping is a promising triage strategy for HPV-positive women, which reduces the reliance on cytology while maintaining non-inferior diagnostic effectiveness for CIN3+ detection, and is suitable for population-based cervical cancer screening.
© 2026 The Authors.
Original languageEnglish
Article number109077
Number of pages8
JournalInternational Journal of Infectious Diseases
Volume171
Online published27 Aug 2026
DOIs
Publication statusPublished - Oct 2026

Funding

This study was supported by National Key R&D Program of China ( 2024YFC2707503 ), Shenzhen Science and Technology Program ( GJHZ20210705142543018 ), Shenzhen Public Platform for Preservation of Fertility and Reproduction ( XMHT20220104049 ), Shenzhen Key Medical Discipline Construction Fund ( SZXK027 ), and research on cervical cancer prevention strategies based on advanced technology ( 2023GDJ001 ). None of the funders had any influence on study design, data collection and analysis, decision to publish, or preparation of this manuscript.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Keywords

  • Cervical cancer
  • Cervical intraepithelial neoplasia
  • Extended HPV genotyping
  • Genotype
  • Human papillomavirus
  • Triage strategy

Publisher's Copyright Statement

  • This full text is made available under CC-BY-NC-ND 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/

Fingerprint

Dive into the research topics of 'Large-cohort screening projects in seven regions of China demonstrate the efficacy of extended HPV genotyping in triaging HPV-positive women'. Together they form a unique fingerprint.

Cite this